Johnny, I like your optimism and enthusiasm. I wish I was as bullish in my predictions as you are, but I don't believe this share structure supports a true run at $3/sh... Even $1 seems more than just a couple of years off.
We have no debt because we have funded our projects by issuing restricted shares. These shares were given at low prices in exchange for funding, and they cannot be sold for 6-12 months (example). As soon as those restrictions are lifted, assuming the SP is improved, those investors will likely take their profits, thus repeating the cycle we've been in for quite some time. Very difficult for a company to sustain sp at this level when they receive funding in this manner
Granted, TAUG has the capability to transcend this cycle with Pilus success, but I keep bringing up share structure for a reason... A billion+ shares for a company this small is too volatile to sustain a $1+ sp.... IMO IMO IMO
Other OTC companies with higher share prices, larger floats, more debt, and less to show for themselves are overvalued and incredibly risky plays. I like Tauriga precisely because of its honest share price.... IMO IMO
Even if Pilus was an overnight success and tomorrow Stantec (for example) wanted to purchase TAUG outright, they'd have to pay about 2 billion dollars if we, as share holders, were to expect our shares to be worth $1 each. Is TAUG worth $2B? Maybe, but probably not yet. IMO
I'm not a professional, so I'm sure my numbers are off, but you get the idea. I like your optimism, but realistically I'd be happy to see us get back to .10 and hold. If we can sustain .10 or better for at least a year, I think a restructuring would be a great consideration to get us trading on a different exchange and attract a whole new class of investors.
